Effect of Babaodan on Tumor Recurrence After Curative Resection of Hepatocellular Carcinoma

NCT03515369 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

459

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Tumor Recurrence

Interventions

DRUG: Babaodan oral capsule
DRUG: Placebo oral capsule

Sponsor

Eastern Hepatobiliary Surgery Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]